LB0001 Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Interim Results from a Phase IIa Study

X. Zeng; C. Wu; J. Hu; S. Liu; Z. Jiang; J. LI; X. Wang; J. Liu; C. Liang; G. Yang

doi:10.1136/annrheumdis-2023-eular.7058

Article info

PDF

Scientific Abstracts

Late Breaking Abstracts

Late-Breaking Oral Abstracts

LB0001 Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Interim Results from a Phase IIa Study

Free

Authors

X. Zeng Peking Union Medical College Hospital, Department of Rheumatology and Clinical Immunology, Beijing, China PubMed articles Google scholar articles
C. Wu Peking Union Medical College Hospital, Department of Rheumatology and Clinical Immunology, Beijing, China PubMed articles Google scholar articles
J. Hu Pingxiang People’s Hospital, Department of Rheumatology and Clinical Immunology, Pingxiang, China PubMed articles Google scholar articles
S. Liu First Affiliated Hospital of Zhengzhou University, Department of Rheumatology and Clinical Immunology, Zhengzhou, China PubMed articles Google scholar articles
Z. Jiang First Affiliated Hospital of Jilin University, Department of Rheumatology and Clinical Immunology, Changchun, China PubMed articles Google scholar articles
J. LI Zhuzhou Central Hospital, Department of Rheumatology and Clinical Immunology, Zhuzhou, China PubMed articles Google scholar articles
X. Wang Second Hospital of Shanxi Medical University, Department of Rheumatology and Clinical Immunology, Taiyuan, Shanxi, China PubMed articles Google scholar articles
J. Liu Jiujiang No. 1 People’s Hospital, Department of Rheumatology and Clinical Immunology, Jiujiang, China PubMed articles Google scholar articles
C. Liang highlightll pharma, N/A, hangzhou, China PubMed articles Google scholar articles
G. Yang highlightll pharma, N/A, hangzhou, China PubMed articles Google scholar articles

Citation

Zeng X, Wu C, Hu J, et al

LB0001 Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Interim Results from a Phase IIa Study

Annals of the Rheumatic Diseases 2023;82:200.

Publication history

First published May 30, 2023.

Online issue publication

August 17, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password